WEDNESDAY, Oct. 21, 2020 — A combination of two “targeted” therapies can beat back a rare form of blood cancer — without the toxic effects of chemotherapy, a new study has found. In a trial of 63 patients, researchers found that the drug regimen frequently wiped out all signs of the cancer — a subtype […]